These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 26900466)

  • 41. Immortalized prairie vole-derived fibroblasts (VMF-K4DTs) can be transformed into pluripotent stem cells and provide a useful tool with which to determine optimal reprogramming conditions.
    Katayama M; Hirayama T; Kiyono T; Onuma M; Tani T; Takeda S; Nishimori K; Fukuda T
    J Reprod Dev; 2017 Jun; 63(3):311-318. PubMed ID: 28331164
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
    Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aberrant DNA methylation reprogramming during induced pluripotent stem cell generation is dependent on the choice of reprogramming factors.
    Planello AC; Ji J; Sharma V; Singhania R; Mbabaali F; Müller F; Alfaro JA; Bock C; De Carvalho DD; Batada NN
    Cell Regen; 2014; 3(1):4. PubMed ID: 25408883
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Rapid and Highly Efficient Method for the Isolation, Purification, and Passaging of Human-Induced Pluripotent Stem Cells.
    Gao X; Sprando RL; Yourick JJ
    Cell Reprogram; 2018 Oct; 20(5):282-288. PubMed ID: 30204478
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induced pluripotent stem cells from goat fibroblasts.
    Song H; Li H; Huang M; Xu D; Gu C; Wang Z; Dong F; Wang F
    Mol Reprod Dev; 2013 Dec; 80(12):1009-17. PubMed ID: 24123501
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Epigenetic Reprogramming Roadmap in Generation of iPSCs from Somatic Cells.
    Brix J; Zhou Y; Luo Y
    J Genet Genomics; 2015 Dec; 42(12):661-70. PubMed ID: 26743984
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An improved method for the derivation of high quality iPSCs in the absence of c-Myc.
    Habib O; Habib G; Choi HW; Hong KS; Do JT; Moon SH; Chung HM
    Exp Cell Res; 2013 Dec; 319(20):3190-200. PubMed ID: 24095950
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of porcine stem cell competence for somatic cell nuclear transfer and production of cloned animals.
    Secher JO; Liu Y; Petkov S; Luo Y; Li D; Hall VJ; Schmidt M; Callesen H; Bentzon JF; Sørensen CB; Freude KK; Hyttel P
    Anim Reprod Sci; 2017 Mar; 178():40-49. PubMed ID: 28126267
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolomic and Transcriptional Analyses Reveal Atmospheric Oxygen During Human Induced Pluripotent Stem Cell Generation Impairs Metabolic Reprogramming.
    Spyrou J; Gardner DK; Harvey AJ
    Stem Cells; 2019 Aug; 37(8):1042-1056. PubMed ID: 31042329
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Establishment of induced pluripotent stem cells from common marmoset fibroblasts by RNA-based reprogramming.
    Nakajima M; Yoshimatsu S; Sato T; Nakamura M; Okahara J; Sasaki E; Shiozawa S; Okano H
    Biochem Biophys Res Commun; 2019 Aug; 515(4):593-599. PubMed ID: 31178141
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Power and the Promise of Cell Reprogramming: Personalized Autologous Body Organ and Cell Transplantation.
    Palomo AB; Lucas M; Dilley RJ; McLenachan S; Chen FK; Requena J; Sal MF; Lucas A; Alvarez I; Jaraquemada D; Edel MJ
    J Clin Med; 2014 Apr; 3(2):373-87. PubMed ID: 26237380
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pluripotent Stem Cells from Domesticated Mammals.
    Ezashi T; Yuan Y; Roberts RM
    Annu Rev Anim Biosci; 2016; 4():223-53. PubMed ID: 26566158
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Metabolic remodeling during somatic cell reprogramming to induced pluripotent stem cells: involvement of hypoxia-inducible factor 1.
    Ishida T; Nakao S; Ueyama T; Harada Y; Kawamura T
    Inflamm Regen; 2020; 40():8. PubMed ID: 32426078
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pluripotent state induction in mouse embryonic fibroblast using mRNAs of reprogramming factors.
    El-Sayed AK; Zhang Z; Zhang L; Liu Z; Abbott LC; Zhang Y; Li B
    Int J Mol Sci; 2014 Nov; 15(12):21840-64. PubMed ID: 25437916
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Veterinary applications of induced pluripotent stem cells: regenerative medicine and models for disease?
    Cebrian-Serrano A; Stout T; Dinnyes A
    Vet J; 2013 Oct; 198(1):34-42. PubMed ID: 24129109
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Concise Review: Embryonic Stem Cells Derived by Somatic Cell Nuclear Transfer: A Horse in the Race?
    Wolf DP; Morey R; Kang E; Ma H; Hayama T; Laurent LC; Mitalipov S
    Stem Cells; 2017 Jan; 35(1):26-34. PubMed ID: 27612640
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Generation of induced pluripotent stem cells from somatic cells.
    Sohn YD; Han JW; Yoon YS
    Prog Mol Biol Transl Sci; 2012; 111():1-26. PubMed ID: 22917224
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Patient-derived induced pluripotent stem cells for models of cancer and cancer stem cell research.
    Chao HM; Chern E
    J Formos Med Assoc; 2018 Dec; 117(12):1046-1057. PubMed ID: 30172452
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of immune response on the use of iPSCs in disease modeling.
    Zhang Z; Huang B; Gao F; Zhang R
    Curr Stem Cell Res Ther; 2015; 10(3):236-44. PubMed ID: 25019961
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reprogramming induced pluripotent stem cells in the absence of c-Myc for differentiation into hepatocyte-like cells.
    Li HY; Chien Y; Chen YJ; Chen SF; Chang YL; Chiang CH; Jeng SY; Chang CM; Wang ML; Chen LK; Hung SI; Huo TI; Lee SD; Chiou SH
    Biomaterials; 2011 Sep; 32(26):5994-6005. PubMed ID: 21658760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.